- Home
- PHAR vs KRO Comparison
PHAR vs KRO Comparison
Compare PHAR & KRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- KRO
- Stock Information
- Founded
- PHAR 1988
- KRO 1916
- Country
- PHAR Netherlands
- KRO United States
- Employees
- PHAR N/A
- KRO N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- KRO Major Chemicals
- Sector
- PHAR Health Care
- KRO Industrials
- Exchange
- PHAR Nasdaq
- KRO Nasdaq
- Market Cap
- PHAR 718.1M
- KRO 803.0M
- IPO Year
- PHAR N/A
- KRO N/A
- Fundamental
- Price
- PHAR $10.45
- KRO $6.01
- Analyst Decision
- PHAR Strong Buy
- KRO Strong Sell
- Analyst Count
- PHAR 3
- KRO 2
- Target Price
- PHAR $30.00
- KRO $7.75
- AVG Volume (30 Days)
- PHAR 2.6K
- KRO 246.2K
- Earning Date
- PHAR 07-31-2025
- KRO 08-06-2025
- Dividend Yield
- PHAR N/A
- KRO 3.31%
- EPS Growth
- PHAR N/A
- KRO N/A
- EPS
- PHAR N/A
- KRO 0.84
- Revenue
- PHAR $320,708,000.00
- KRO $1,898,100,000.00
- Revenue This Year
- PHAR $13.31
- KRO $8.42
- Revenue Next Year
- PHAR $7.68
- KRO $11.49
- P/E Ratio
- PHAR N/A
- KRO $7.23
- Revenue Growth
- PHAR 24.13
- KRO 10.42
- 52 Week Low
- PHAR $6.65
- KRO $5.98
- 52 Week High
- PHAR $12.61
- KRO $13.91
- Technical
- Relative Strength Index (RSI)
- PHAR 47.51
- KRO 34.52
- Support Level
- PHAR $10.41
- KRO $5.98
- Resistance Level
- PHAR $11.50
- KRO $6.22
- Average True Range (ATR)
- PHAR 0.32
- KRO 0.25
- MACD
- PHAR -0.17
- KRO -0.03
- Stochastic Oscillator
- PHAR 2.26
- KRO 2.75
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About KRO Kronos Worldwide Inc
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in various products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.